Novel GLI3 variant causing overlapped Greig cephalopolysyndactyly syndrome (GCPS) and Pallister-Hall syndrome (PHS) phenotype with agenesis of gallbladder and pancreas
- 374 Downloads
A proper balance between the activator and the repressor form of GLI3, a zinc-finger transcription factor downstream of hedgehog signaling, is essential for proper development of various organs during development. Mutations in different domains of the GLI3 gene underlie several congenital diseases including Greig cephalopolysyndactyly syndrome (GCPS) and Pallister-Hall syndrome (PHS).
Here, we describe the case of an overlapped phenotype of these syndromes with agenesis of the gallbladder and the pancreas, bearing a c.2155 C > T novel likely pathogenic variant of GLI3 gene by missense point mutation causing p.P719S at the proteolytic cleavage site.
Although agenesis of the gallbladder and the pancreas is uncommon in GLI3 morphopathy, a slight difference in the gradient or the balance between activator and repressor in this case may hinder sophisticated spatial and sequential hedgehog signaling that is essential for proper development of gallbladder and pancreas from endodermal buds.
KeywordsGLI3 Hedgehog Greig cephalopolysyndactyly syndrome Pallister-hall syndrome
CREB binding protein domain
Greig cephalopolysyndactyly syndrome
Proteolytic cleavage site
Polymerase chain reaction
Zinc-finger DNA binding domain
GLI3 is a zinc-finger transcription factor that mediate the sonic hedgehog (SHH) signaling acting as both a transcriptional activator and repressor during development [1, 2]. When the SHH is present, full-length GLI3 up-regulates its target genes, whereas when the SHH is absent, GLI3 is cleaved to yield a repressor that down-regulates those genes . The pathogenic variants of GLI3 gene cause various malformations including Greig cephalopolysyndactyly (GCPS) syndrome  and Pallister-Hall syndrome (PHS)  in an autosomal dominant pattern. Although GCPS and PHS have some distinct clinical presentations (GCPS is characterized by polysyndactyly, macrocephaly, hypertelorism, and PHS is characterized by hypothalamic hamartoma, bifid epiglottis, and insertional polydactyly), the apparent lack of GLI3 genotype-phenotype correlation occasionally precludes clear phenotypic classification . Described here is a case of an overlapped GCPS and PHS phenotype with agenesis of the gallbladder and the pancreas, bearing a novel likely pathogenic GLI3 variant by point mutation.
The 31-year-old woman, gravida-1 para-1, with no apparent risk factors for congenital anomaly, achieved natural pregnancy. Oligohydramnios and intrauterine growth restriction was, however, noted at 14 weeks of gestation. Amniocentesis, carried out at 16 weeks of gestation for chromosomal analyzes, revealed a normal 46, XY male karyotype pattern. At 30 weeks of gestation, echographic examination revealed loss of fetal movement; intrauterine fetal death was confirmed 3 days thereafter, and the fetus was delivered by artificial abortion.
Thyroidal atrophy, adrenal atrophy
Malrotation of intestine, atresia of anus, agenesis of gallbladder, agenesis of pancreas
Bilateral hypoplasia of kidney
Bilateral cryptorchidism, external genitalia hypoplasia, and hypospadias
Postaxial polysyndactyly, and polysplenia,
GLI3 comprises several functional domains: repressor domain (RD, aa106-aa263), zinc-finger DNA binding domain (ZNF, aa462-aa645), proteolytic cleavage site (PC, aa703-aa740), CREB binding protein domain (CBP, 827-1131), transactivation domain 2 (TA2, aa1044-aa1322) and transactivation domain 1 (TA1, aa1376- aa1580), [7, 8]. GLI3 has a dual function as a transcriptional activator and a repressor of the SHH pathway — the full-length GLI3 acts as an activator after phosphorylation and nuclear translocation, while its C-terminally truncated form by protease clearage acts as a repressor [3, 9, 10]. A proper balance between the GLI3 activator and the repressor, organized by hedgehog signaling, elicits proper evolvement of the various organs during development [11, 12, 13]. Pathogenic variants in different domains of the gene underlie several congenital diseases including GCPS (MIM ID#175700), PHS (MIM ID #146510), preaxial polydactyly type IV (MIM ID #174700), and postaxial polydactyly types A1 and B (MIM ID #174200), Acrocallosal Syndrome (MIM ID #200990), trigonocephaly with craniosynostosis and polydactyly, and some types of oral-facial-digital syndromes . Typical GCPS involves polysyndactyly of hands and feet, and craniofacial abnormality. Different genetic alterations (from chromosomal deletion to a single nucleic acid mutation in the ZNF domain that reduces the functioning of both the activator and repressor forms of the GLI3 protein) cause GCPS . PHS, on the other hand, shows a lethal condition involving hypothalamic dysfunction, skeletal limb defects, craniofacial and urogenital malformation attributed to pathogenic variants of GLI3 gene, typically within or around the PC domain of the GLI3 protein, resulting in a relative reduction in the functioning of the GLI3 repressor form . Since a delicate balance between the functioning activator and repressor is essential for proper development [2, 17, 18], the simple location of the pathogenic variants in GLI3 site does not always clearly correlate with the clinical manifestations . Also, some pathogenic variants cause overlapping phenotypes of GCPS and PHS . Therefore, the concept of GLI3 morphopathies has been postulated to designate these mutually overlapped syndromes .
In the current study, we demonstrated a case of GLI3 morphopathy attributed to a novel likely pathogenic variant by missense mutation at the PC domain (p.P719S) of GLI3 (variant was judged as likely pathogenic based on the criteria by American College of Medical Genetics and Genomics and the Association for Molecular Pathology, ACMG standards and guidelines ). Indeed, in silico predictions of the newly found variant (p.P719S) of GLI3 gene via the predictive algorithms (PolyPhen-2, http://genetics.bwh.harvard.edu/pph2) shows that this mutation is predicted to be “PROBABLY DAMAGING” with a score of 0.963 (sensitivity: 0.78; specificity: 0.95).Interestingly, besides gastrointestinal malformations, agenesis of both the gallbladder and the pancreas was observed. During the early stages of organogenesis, the liver, the gallbladder and the biliary duct system arise as buds in the endodermal epithelium at the distal end of the foregut. A small caudal portion of the liver bud then expands to form the gallbladder . The pancreas develops also from the endodermal epithelium of the duodenal diverticula, initially as two separate dorsal and ventral pancreatic buds, which then fuse when the duodenum rotates . SHH signaling is expressed in the ventral foregut endoderm from which the liver derives, and its expression disappears at the onset of liver bud formation [21, 22]. Such sophisticated spatial and sequential SHH signaling is essential for proper organ development from these endodermal buds. Because we have not done comprehensive genomics study, possibility of coincidental additional pathogenic variants in Pdx1, Ptf1a, Gata4 and Gata6, known to be associated with agenesis of pancreas , cannot be excluded in this case. Although it remains unclear why agenesis of the gallbladder and the pancreas is uncommon in GLI3 morphopathy, a slight difference in the gradient or the balance between activator and repressor induced by a slight difference of protein tertiary structure may contribute to the apparent phenotypic difference in GLI morphopathy.
In conclusion, this case is an extreme example in which slight difference of genetic alterations in the same gene may result in considerable morphological variations, when sophisticated spatial and sequential expression of the gene is essential and critical for proper development.
The authors are sincerely grateful to Ms. Yuki Takaoka and Ms. Chie Shiraishi for their technical assistance.
SK and RK receive research support from the Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI, #16H05161 and 15 K08426, respectively).
Availability of data and materials
Please contact the Authors for data requests.
SI designed the study, carried out the experiments and drafted the manuscript; RH, TK, AO, YU carried out the histopatologic evaluation. RK performed molecular pathological interpretation of the case. SK organized whole study and wrote the manuscript. All authors read and approved the final manuscript.
Ethics approval and consent to participate
All procedures followed were in accordance with the ethical standards of the ethical committee of the Ehime University Hospital on human experimentation and with the Helsinki Declaration of 1964 and later versions.
Consent for publication
Written informed consent for publication of their clinical details and/or clinical images was obtained from the relatives of the patient. A copy of the consent form is available for review by the Editor of this journal.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
- 4.Biesecker LG. Pallister-Hall Syndrome. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, et al., editors. GeneReviews(R). Seattle (WA)1993.Google Scholar
- 7.Walterhouse D, Ahmed M, Slusarski D, Kalamaras J, Boucher D, Holmgren R, et al. Gli, a zinc finger transcription factor and oncogene, is expressed during normal mouse development. Dev Dyn. 1993;196(2):91–102. doi: https://doi.org/10.1002/aja.1001960203. PubMed PMID: 8364225CrossRefPubMedGoogle Scholar
- 8.Krauss S, So J, Hambrock M, Kohler A, Kunath M, Scharff C, et al. Point mutations in GLI3 lead to misregulation of its subcellular localization. PLoS One. 2009;4(10):e7471. doi: https://doi.org/10.1371/journal.pone.0007471. PubMed PMID: 19829694; PubMed Central PMCID: PMCPMC2758996CrossRefPubMedPubMedCentralGoogle Scholar
- 10.Cao T, Wang C, Yang M, Wu C, Wang B. Mouse limbs expressing only the Gli3 repressor resemble those of sonic hedgehog mutants. Dev Biol. 2013;379(2):221–8. doi: https://doi.org/10.1016/j.ydbio.2013.04.025. PubMed PMID: 23644062; PubMed Central PMCID: PMCPMC3707282.CrossRefPubMedPubMedCentralGoogle Scholar
- 12.Li J, Wang C, Pan Y, Bai Z, Wang B. Increased proteolytic processing of full-length Gli2 transcription factor reduces the hedgehog pathway activity in vivo. Dev Dyn. 2011;240(4):766–74. doi: https://doi.org/10.1002/dvdy.22578. PubMed PMID: 21337666; PubMed Central PMCID: PMCPMC3071291.CrossRefPubMedPubMedCentralGoogle Scholar
- 13.Qin J, Lin Y, Norman RX, Ko HW, Eggenschwiler JT. Intraflagellar transport protein 122 antagonizes sonic hedgehog signaling and controls ciliary localization of pathway components. Proc Natl Acad Sci U S A. 2011;108(4):1456–61. doi: https://doi.org/10.1073/pnas.1011410108. PubMed PMID: 21209331; PubMed Central PMCID: PMCPMC3029728CrossRefPubMedPubMedCentralGoogle Scholar
- 14.Al-Qattan MM, Shamseldin HE, Salih MA, Alkuraya FS. GLI3-related polydactyly: a review. Clin Genet. 2017; doi: https://doi.org/10.1111/cge.12952. PubMed PMID: 28224613
- 15.Biesecker LG. Greig Cephalopolysyndactyly Syndrome. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, et al., editors. GeneReviews(R). Seattle (WA)1993.Google Scholar
- 19.Demurger F, Ichkou A, Mougou-Zerelli S, Le Merrer M, Goudefroye G, Delezoide AL, et al. New insights into genotype-phenotype correlation for GLI3 mutations. Eur J Hum Genet. 2015;23(1):92–102. doi: https://doi.org/10.1038/ejhg.2014.62. PubMed PMID: 24736735; PubMed Central PMCID: PMCPMC4266745CrossRefPubMedGoogle Scholar
- 20.Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24. doi: https://doi.org/10.1038/gim.2015.30. PubMed PMID: 25741868; PubMed Central PMCID: PMCPMC4544753CrossRefPubMedPubMedCentralGoogle Scholar
- 21.Bogue CW, Ganea GR, Sturm E, Ianucci R, Jacobs HC. Hex expression suggests a role in the development and function of organs derived from foregut endoderm. Dev Dyn. 2000;219(1):84–9. doi: https://doi.org/10.1002/1097-0177(2000)9999:9999<::AID-DVDY1028>3.0.CO;2-5. PubMed PMID: 10974674CrossRefPubMedGoogle Scholar
- 23.Teo AK, Lau HH, Valdez IA, Dirice E, Tjora E, Raeder H, et al. Early developmental perturbations in a human stem cell model of MODY5/HNF1B pancreatic Hypoplasia. Stem Cell Reports. 2016;6(3):357–67. doi: https://doi.org/10.1016/j.stemcr.2016.01.007. PubMed PMID: 26876668; PubMed Central PMCID: PMCPMC4788763CrossRefPubMedPubMedCentralGoogle Scholar
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.